Asthma Therapeutics Market Growth and Segment Forecasts to 2020

Technavio Announces the Publication of its Research Report – Global Asthma Therapeutics Market 2016-2020

Technavio recognizes the following companies as the key players in the global asthma therapeutics market: AstraZeneca, Boehringer Ingelheim, F. Hoffmann-La Roche, GSK, Merck,

Other Prominent Vendors in the market are: ALK-Abello, Amgen, Array BioPharma, Asmacure, Astellas Pharma, Axikin Pharmaceuticals, Chiesi Farmaceutici, Dynavax Technologies, Horizon Pharma, Hovione Scientia, Invion, Ivax, Kissei Pharmaceutical, Kyowa Hakko Kirin, MediciNova, Mitsubishi Tanabe Pharma, Mundipharma, Nycomed, Oxagen Limited, Palobiofarma, Pearl Therapeutics, Pharmaking, Pharmaxis, Pulmagen Therapeutics, Regeneron Pharmaceuticals, Revalesio, RSPR Pharma AB, SAMA Pharmaceuticals, Sanofi, Skyepharma, SolAeroMed, Stallergenes, Sterna Biologicals, Synairgen, Theron Pharmaceuticals, UCB Pharma, Vectura, Verona Pharma, and Whanin Pharmaceutical.

Browse full report with TOC@ https://marketreportscenter.com/reports/349432/global-asthma-therapeutics-market-2016-2020

Commenting on the report, an analyst from Technavio’s team said: “One of the key trends for market growth will be innovative technologies for drug delivery. The industry's shift toward electronic systems technology like smart technology and EHR brings the level of perspective and accessibility across healthcare specialties. This reduces cost when administering expensive medications. Other recent advances include integration of add-on devices such as spacers, breath-actuated devices, and valved holding chambers in inhalers.

They help in reducing oropharyngeal deposition of inhaled corticosteroids and minimizes side effects.

”

According to the report, one of the key drivers for market growth will be huge market potential for mAbs. mAbs will have a high uptake for the treatment of asthma, owing to the development of target specific drugs. mAbs blocking IgE are specifically approved for the treatment of allergic...